254 related articles for article (PubMed ID: 22883707)
21. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
[TBL] [Abstract][Full Text] [Related]
22. Beta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure.
Gage JR; Fonarow G; Hamilton M; Widawski M; Martínez-Maza O; Vredevoe DL
Neuroimmunomodulation; 2004; 11(3):173-80. PubMed ID: 15067208
[TBL] [Abstract][Full Text] [Related]
23. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
[TBL] [Abstract][Full Text] [Related]
24. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
Iwakura Y; Nakae S; Saijo S; Ishigame H
Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
[TBL] [Abstract][Full Text] [Related]
25. Targeting IL-23 in autoimmunity.
Hölscher C
Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
[TBL] [Abstract][Full Text] [Related]
26. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes.
Duarte PM; Miranda TS; Lima JA; Dias Gonçalves TE; Santos VR; Bastos MF; Ribeiro FV
J Periodontol; 2012 Apr; 83(4):426-34. PubMed ID: 21859322
[TBL] [Abstract][Full Text] [Related]
27. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
28. Cytokine dysregulation, inflammation and well-being.
Elenkov IJ; Iezzoni DG; Daly A; Harris AG; Chrousos GP
Neuroimmunomodulation; 2005; 12(5):255-69. PubMed ID: 16166805
[TBL] [Abstract][Full Text] [Related]
29. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
30. IL-17-producing T cells in lung immunity and inflammation.
Nembrini C; Marsland BJ; Kopf M
J Allergy Clin Immunol; 2009 May; 123(5):986-94; quiz 995-6. PubMed ID: 19410688
[TBL] [Abstract][Full Text] [Related]
31. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract.
Fuchs A; Colonna M
Curr Opin Gastroenterol; 2013 Nov; 29(6):581-7. PubMed ID: 24100718
[TBL] [Abstract][Full Text] [Related]
32. Role of Inflammation Amplifier-Induced Growth Factor Expression in the Development of Inflammatory Diseases.
Nakagawa I; Kamimura D; Atsumi T; Arima Y; Murakami M
Crit Rev Immunol; 2015; 35(5):365-78. PubMed ID: 26853849
[TBL] [Abstract][Full Text] [Related]
33. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zhang Z; Hinrichs DJ; Lu H; Chen H; Zhong W; Kolls JK
Int Immunopharmacol; 2007 Apr; 7(4):409-16. PubMed ID: 17321463
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
Dinarello CA
Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950
[TBL] [Abstract][Full Text] [Related]
35. [Molecular mechanisms of the acute phase reaction and innate immunological response].
Koj A
Przegl Lek; 2010; 67(7):466-71. PubMed ID: 21387757
[TBL] [Abstract][Full Text] [Related]
36. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines.
Barak V; Birkenfeld S; Halperin T; Kalickman I
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):919-22. PubMed ID: 12455180
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-18: biological properties and clinical implications.
Lebel-Binay S; Berger A; Zinzindohoué F; Cugnenc P; Thiounn N; Fridman WH; Pagès F
Eur Cytokine Netw; 2000 Mar; 11(1):15-26. PubMed ID: 10705295
[TBL] [Abstract][Full Text] [Related]
38. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-17-producing T helper cells in autoimmunity.
Hemdan NY; Birkenmeier G; Wichmann G; Abu El-Saad AM; Krieger T; Conrad K; Sack U
Autoimmun Rev; 2010 Sep; 9(11):785-92. PubMed ID: 20647062
[TBL] [Abstract][Full Text] [Related]
40. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
